Cosimo Misciali

Dr. Cosimo Misciali

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2019 in Dermatology Practical & Conceptual
Verified
Journal Article
Open access
PDF file
AAAurora Maria Alessandrini
Aurora Maria Alessandrini
MSMichela Starace
Michela Starace
FBFrancesca Bruni
Francesca Bruni
NBNicolò Brandi
Nicolò Brandi
CBCarlotta Baraldi
Carlotta Baraldi
Bianca Maria PiracciniBianca Maria Piraccini
Bianca Maria Piraccini
Background: Alopecia areata is a nonscarring hair loss that usually causes round patches of baldness, but alopecia areata incognita (AAI) and diffuse alopecia areata (DAA) can cause a diffuse and acute pattern of hair loss. Objective: To analyze the clinical, trichoscopic, histological, and therapeutic features of AAI and DAA. Methods: The study was designed to include data of patients with histological diagnosis of AAI and DAA enrolled in our Hair Disease Outpatient Consultations. Results: DAA had a greater involvement of the parietal and anterior-temporal regions, while AAI manifested itself mainly in the occipital-parietal regions. The most frequent pattern was empty yellow dots, yellow dots with vellus hairs, and small hair in regrowth, but the presence of pigtail hair was found almost exclusively in those with AAI. In cases of DDA, the finding of dystrophic hair and black dots was more frequent. The most frequent trichoscopic sign in both diseases was the presence of empty yellow dots, which, however, were described in a higher percentage in cases of DAA. The diseases have a benign course and are responsive to topical steroid therapy. Conclusions: Trichoscopy is very important for the differential diagnosis between the 2 diseases and to select the best site for biopsy. In the presence of diffuse hair thinning, these entities must be considered.

3 February 2021 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
AAAmbra Di Altobrando
Ambra Di Altobrando
CMCosimo Misciali
Cosimo Misciali
BRBeatrice Raone
Beatrice Raone
LALuciano Attard
Luciano Attard
VGValeria Gaspari
Valeria Gaspari
With an estimated prevalence of 0.7%, pyoderma gangrenosum (PG) is the most frequent type of reactive skin lesions seen in the setting of inflammatory bowel disease, together with metastatic Crohn’s disease. However, in the case of persistent cutaneous ulcerations in patients with Crohn’s disease under biologic and/or immunosuppressive therapy, infectious or malignant etiologies should be excluded. We report a case of multiple difficult-to-treat skin ulcerations due to Leishmania in a patient with Crohn’s disease treated with antitumor necrosis factor-alpha drugs, misinterpreted for a long time as PG.

25 February 2025 in Dermatopathology
Verified
Journal Article
Open access
PDF file
BSBiagio Scotti
Biagio Scotti
CMCosimo Misciali
Cosimo Misciali
FBFederico Bardazzi
Federico Bardazzi
Bianca Maria PiracciniBianca Maria Piraccini
Bianca Maria Piraccini
Michelangelo La PlacaMichelangelo La Placa
Michelangelo La Placa
Hypertrophic lichen planus (HLP) is a chronic inflammatory skin condition defined by verrucous, pruritic, papules and plaques usually affecting the lower limbs. The diagnosis of HLP is primarily clinical. However, due to its feasible generalized presentation and similarities with other hypertrophic cutaneous disorders, histological evaluation is often necessary. Many dermatological conditions that present with a hypertrophic clinical appearance can arise from a histological lichenoid infiltrate (HCLI). Hence, we provide an overview of the clinical, histopathological, and prognostic features of selected HCLI, including HLP, hypertrophic lichenoid dermatitis, hypertrophic lichen sclerosus (HLS), lichen simplex chronicus (LSC), squamous cell carcinoma (SCC), keratoacanthoma (KA), pseudoepitheliomatous hyperplasia (PEH), viral warts, and lupus erythematosus/lichen planus (LE/LP) overlap. Choosing the appropriate procedure and the anatomical site for an incisional biopsy requires thoughtful consideration to ensure sufficient depth and improve diagnostic accuracy by identifying the histological features specific to each hypertrophic condition.

29 February 2024 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
MSMichela Starace
Michela Starace
LRLuca Rapparini
Luca Rapparini
SCStephano Cedirian
Stephano Cedirian
VEValeria Evangelista
Valeria Evangelista
FPFrancesca Pampaloni
Francesca Pampaloni
Bianca Maria PiracciniBianca Maria Piraccini
Bianca Maria Piraccini

Verified
Journal Article
Open access
PDF file
MSMichela Starace
Michela Starace
FPFrancesca Pampaloni
Francesca Pampaloni
FBFrancesca Bruni
Francesca Bruni
FQFederico Quadrelli
Federico Quadrelli
SCStephano Cedirian
Stephano Cedirian
Bianca Maria PiracciniBianca Maria Piraccini
Bianca Maria Piraccini
Collagen VI-related myopathies are characterized by severe muscle involvement and skin involvement (keratosis pilaris and impaired healing with the development of abnormal scars, especially keloids). Scalp involvement and hair loss have not been reported among cutaneous changes associated with collagen VI mutations. The aim of this study is to describe the clinical, trichoscopic, and histological findings of the scalp changes in patients affected by COL VI mutations and to estimate their prevalence. Patients with Ullrich congenital muscular dystrophy were enrolled and underwent clinical and trichoscopic examinations and a scalp biopsy for histopathology. Five patients were enrolled, and all complained of hair loss and scalp itching. One patient showed yellow interfollicular scales with erythema and dilated, branched vessels, and the histological findings were suggestive of scalp psoriasis. Two patients presented with scarring alopecia patches on the vertex area, and they were histologically diagnosed with folliculitis decalvans. The last two patients presented with scaling and hair thinning, but they were both diagnosed with folliculitis and perifolliculitis. Ten more patients answered to a “scalp involvement questionnaire”, and six of them confirmed to have or have had scalp disorders and/or itching. Scalp involvement can be associated with COL VI mutations and should be investigated.

6 July 2025 in Cancers
Verified
Journal Article
Open access
PDF file
BSBiagio Scotti
Biagio Scotti
EBElisabetta Broseghini
Elisabetta Broseghini
CRConstantino Ricci
Constantino Ricci
BCBarbara Corti
Barbara Corti
CVCostanza Viola
Costanza Viola
Emi DikaEmi Dika
Emi Dika
Background/objectives: Despite advancements in early diagnosis and clinical practices guided by standardized care protocols, Merkel cell carcinoma (MCC) is marked by an unfavorable prognosis with a 5-year relative survival rate of 65%, based primarily on data collected prior to the introduction of immunotherapy. Regional nodal metastases affect 40–50% of MCC patients, while approximately 33% experience distant dissemination. Among these, bone and bone marrow metastases are particularly notable, although the characteristics and clinical implications of this metastatic disease in MCC remain poorly understood. Methods: A comprehensive review was conducted using the Medline database (via PubMed) up to January 2025. The search strategy included the string “(Merkel cell carcinoma AND (bone OR marrow))”. Results: A total of 1133 (69.3% male and 30.7% female) patients diagnosed with advanced MCC were collected. The median (IQR) age at diagnosis was 67.5 (12.65) years old. Overall, 201 (20.8%) cases of bone and/or bone marrow metastases were identified and linked to a primary known MCC in 75.7% of cases. Bone metastases (BMs) appear as the third most common metastatic site, following the liver (second) and lymph nodes (first). They show mixed biological and radiological behavior, with a marked preference for the axial skeleton over the appendicular one. Addressing the characteristics of metastatic bone disease, neurological symptoms were the most documented, whereas bone marrow involvement and leukemic spread seemed to be primarily related to immunosuppression. Multimodal treatment strategies, including platinum-based chemotherapy and radiotherapy, were the primary approaches adopted, reflecting therapeutic practices from the pre-immunotherapy era. Conclusions: The pattern of metastatic spread in MCC differs among studies, with the bones resulting as the third most common site of distant spread. Excluding head and neck MCC, which seems to be more regularly associated with liver metastases, the relationship between the primary tumor site and the development of bone or bone marrow metastases appears inconsistent. Overall, BMs mostly correlated with advanced MCC stages and poorer survival outcomes, with a median overall survival (OS) of 8 months (range 12.75–4). The integration of international guidelines, evolving evidence from clinical trials, and the expanding role of immune checkpoint inhibitors (ICIs) will contribute to improving systemic disease control and enhance patient care.